Stay updated on Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial page.
Latest updates to the Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe website has added new features while removing extensive options for downloading study data, including various file formats and detailed data fields.SummaryDifference2%
- Check20 days agoChange DetectedThe website has been updated with new data fields and a revised version (v2.12.2) for the MK-3475-937 study, while the previous version (v2.12.1) and an older identifier have been removed.SummaryDifference2%
- Check35 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.1, indicating a new release with potential improvements or features.SummaryDifference0.1%
- Check66 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.0%
- Check73 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, and a notice regarding delays in study record information has been deleted.SummaryDifference0.4%
- Check81 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference0.4%
Stay in the know with updates to Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial page.